Sonora Investment Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $3K | Hold |
39
| – | – | ﹤0.01% | 966 |
|
2021
Q2 | $3K | Hold |
39
| – | – | ﹤0.01% | 872 |
|
2021
Q1 | $3K | Hold |
39
| – | – | ﹤0.01% | 1642 |
|
2020
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 1607 |
|
2020
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 1662 |
|
2020
Q2 | $5K | Hold |
39
| – | – | ﹤0.01% | 1381 |
|
2020
Q1 | $2K | Hold |
39
| – | – | ﹤0.01% | 1513 |
|
2019
Q4 | $5K | Hold |
39
| – | – | ﹤0.01% | 1424 |
|
2019
Q3 | $5K | Hold |
39
| – | – | ﹤0.01% | 1413 |
|
2019
Q2 | $12K | Hold |
39
| – | – | ﹤0.01% | 1068 |
|
2019
Q1 | $18K | Hold |
39
| – | – | ﹤0.01% | 837 |
|
2018
Q4 | $18K | Buy |
39
+6
| +18% | +$2.77K | ﹤0.01% | 682 |
|
2018
Q3 | $30K | Buy |
33
+14
| +74% | +$12.7K | ﹤0.01% | 512 |
|
2018
Q2 | $11K | Hold |
19
| – | – | ﹤0.01% | 762 |
|
2018
Q1 | $12.7K | Hold |
19
| – | – | ﹤0.01% | 703 |
|
2017
Q4 | $7.11K | Sell |
19
-12
| -39% | -$4.49K | ﹤0.01% | 897 |
|
2017
Q3 | $9.35K | Buy |
31
+12
| +63% | +$3.62K | ﹤0.01% | 744 |
|
2017
Q2 | $9.31K | Hold |
19
| – | – | ﹤0.01% | 743 |
|
2017
Q1 | $24.2K | Hold |
19
| – | – | ﹤0.01% | 475 |
|
2016
Q4 | $7.84K | Hold |
19
| – | – | ﹤0.01% | 646 |
|
2016
Q3 | $7.95K | Hold |
19
| – | – | ﹤0.01% | 630 |
|
2016
Q2 | $9.52K | Hold |
19
| – | – | ﹤0.01% | 604 |
|
2016
Q1 | $10.2K | Buy |
19
+11
| +138% | +$5.9K | ﹤0.01% | 641 |
|
2015
Q4 | $7K | Buy |
8
+5
| +167% | +$4.38K | ﹤0.01% | 597 |
|
2015
Q3 | $3K | Buy |
+3
| New | +$3K | ﹤0.01% | 933 |
|